Third Rock Ventures II, L.P. - 10%+ Owner at Jounce Therapeutics, Inc.

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
JNCE
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Third Rock Ventures II, L.P. since 22 Oct 2025

Reported holdings for Third Rock Ventures II, L.P. in Jounce Therapeutics, Inc.

Form 4 holding 10%+ Owner

Jounce Therapeutics, Inc.

Security class
Common Stock
Shares / value
3,048,780
Estimated value
$5,640,243
Report date
15 Sep 2021
Price
$1.85
Ownership
Indirect
Form 4 holding 10%+ Owner

Jounce Therapeutics, Inc.

Security class
Common Stock
Shares / value
2,697,829
Estimated value
$4,990,984
Report date
15 Sep 2021
Price
$1.85
Ownership
Direct

Transaction history for Third Rock Ventures II, L.P. in Jounce Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .